Feb 16, 2021 | Webinar

What is the place of urinary markers in NMIBC follow-up?

Watch the webinar by Prof. Fred Witjes

On Thursday 21 January 2021, MML-Medical, partner of Nucleix in the Netherlands, organised the webinar “Follow-up of NMIBC, including the place of urinary markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes, Professor of oncological urology, and 15 minutes Q&A, chaired by Dr. Toine van der Heijden, oncological urologist, both from the Radboud UMC Nijmegen, the Netherlands.

Watch this webinar to learn more about:

  • The current guidelines on treatment and follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC)
  • The pitfalls of the current follow-up procedures
  • Urinary markers in follow-up of NMIBC and promising results from clinical studies
  • Practical considerations about using biomarker tests in clinical practice

Other updates

Epigenetic marker for the monitoring of bladder tumours

Watch the presentation of Dr. Fernando Lozano Palacio (Barcelona, Spain) During the virtual VI Symposium Liquid Biopsy, organised from 25 till 27 January 2021 by a scientific committee from the University Hospital of Santiago (Spain), Dr. Fernando Lozano Palacio from...

read more

Webinar on Bladder EpiCheck®, for NMIBC monitoring

On Tuesday October 6th  2020, Nucleix, Israel and Palex Medical, Spain organised the webinar “Bladder EpiCheck®, for accurate, non-invasive bladder cancer monitoring”. Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands,...

read more